MarioLevis82 Profile Banner
Mario Levis Profile
Mario Levis

@MarioLevis82

Followers
101
Following
151
Media
6
Statuses
64

Radiation Oncologist, involved in clinical research and treatment of #lymphomas #braintumors Assistant Professor @Unito, Department of Oncology, Turin, Italy🇮🇹

Torino, Piemonte
Joined April 2018
Don't wanna be here? Send us removal request.
@Icro_Meattini
Icro Meattini
4 months
Amazing to chair the @escardio @ESTRO_RT joint session today in #Florence alongside Mario Levis and Maja Maraldo at #ESCardioOnco2025 A vibrant and inspiring discussion — reinforcing the vital need for a truly multidisciplinary approach in #CardioOnc @OncoAlert #OncoAlert
3
4
33
@a_dalpra
Alan Dal Pra, MD
10 months
Congratulations on organizing such a great #TOP2024 meeting! It was a huge honor to visit beautiful Piemonte 🇮🇹 and connect with the fantastic #radonc and GU teams at @UroMolinette at the University of Turin. The hospitality of @peppinoiorio and the team is simply unmatched.
@GMarra_MD
Giancarlo Marra
10 months
Thank you @a_dalpra for coming to #torino great to meet you & 🔝☢️ overview in #PCa #looking forward to the next one 🇮🇹🇪🇺🇺🇸
1
4
16
@peppinoiorio
GiuseppeC. Iorio MD
1 year
“Ablative Radiotherapy in the non-oncological arena” Fantastic overview by #MarziaCerrato and a terrific kick-off for @airo_young @VSalvestrini @Valerio_Nardone @LCUBLD @GrassiRoberta89 @NicosiaMd @FDeFelice_ @PierluigiBonomo @Atem84 #AIRO2024
0
7
14
@peppinoiorio
GiuseppeC. Iorio MD
1 year
Huge congratulations to President @BarbaraJereczek 👏👏👏🏴󠁧󠁢󠁳󠁣󠁴󠁿 @ESTRO_RT a bright future ahead of our Society!
0
6
14
@peppinoiorio
GiuseppeC. Iorio MD
1 year
0
5
15
@michaelsbinkley
Michael Sargent Binkley
2 years
Monumental effort by GLOW team in publishing the largest analysis of NLPHL to date and answering many key questions about age specific risks, the prognostic impact of variant patterns, and developing a new LP-IPS: https://t.co/kuGpmIMEsh @glow_nlphl @JCO_ASCO @JamieFlerlage
Tweet card summary image
ascopubs.org
PURPOSENodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and large international cooperative efforts are needed to evaluate the significance of clinical risk factors and...
0
18
50
@MarioLevis82
Mario Levis
2 years
#AIRO2023, Great team! Non-oncologic Ablative Treatments
1
0
4
@MarioLevis82
Mario Levis
2 years
Kick-off meeting of the group on “Non-oncological ablative treatments” at #AIRO2023. The ball is rolling now! Amazing collaboration starting with @AIACaritmologia on Cardiac radioablation. Thank Dr. Corrado Carbucicchio for exciting talk! @FiorentinoAlba @BarbaraJereczek
1
1
5
@MarioLevis82
Mario Levis
2 years
Exciting talk on the new frontier of Stereotactic Arrhythmia Radioablation by @FiorentinoAlba at #AIRO2023. A bright future ahead of us on this exciting field! @BarbaraJereczek @Niccolo_Manjuba
0
0
10
@IJROBP
IJROBP - The Red Journal
2 years
Great podcast that tells you everything you need to know about how to radiate recurrent/refractory lymphoma in the setting of transplant or CAR-T. Direct link at: https://t.co/CpdmyjBrQA @belinda_campbe @MarioLevis82 @MayoCancerCare @ILROGTeam
3
13
29
@ESTRO_RT
ESTRO
2 years
💼 The Evidence Based Radiation Oncology course gathered 135 participants last week in Jakarta! The faculty would like to thank Prof Soehartati A. Gondhowiardjo, Dr Gregorius Ben Prajogi, IROS & SEAROG for their hospitality in hosting the ESTRO course in the city. Terima kasih!🌏
0
4
22
@glow_nlphl
GLOW: Global nLPHL One Working Group
2 years
We are proud to announce this abstract by Drs. @michaelsbinkley & @JamieFlerlage, to be presented this Friday @icmlugano #17ICML. Through our @glow_nlphl consortium, this is the largest cohort described of >2100 patients with NLPHL. #NLPHLsm #lymsm https://t.co/mepZ5cHNnk
3
10
23
@Accuray
Accuray
2 years
We will be at the @ESTRO_RT Course: IMRT/VMAT and Other Highly Conformal Techniques in Clinical Practice course, in Turin, Italy on June 4th-8th. Join us and come meet our experts! #AccurayExpandRT
1
2
5
@MarioLevis82
Mario Levis
2 years
Exciting #ESTRO2023 meeting in Wien. Several inspiring sessions and outstanding talks. RT @unito is here!!
0
0
9
@JamesBatesMD
James Bates
2 years
Standing room only for oral session on Radiotherapy and the Heart @ESTRO_RT #ESTRO23 - great to see this much interest in the topic! Great moderation from @DavidJCutter and Hamza Alghamdi
0
1
9
@GeorgeMikhaeel
George Mikhaeel
2 years
2 great presentations from MSKCC team on the largest series of PCNSL to-date. #ESTRO23 #radonc #lymsm
1
5
14
@JamesBatesMD
James Bates
2 years
Another awesome session from @ESTRO_RT and @escardio at #ESTRO23 on cardio-oncology guidelines - @marianneaznar talking about need for substructure data - exciting things coming! @DrRebeccaHowel1 @SShrestha_1
0
1
4
@peppinoiorio
GiuseppeC. Iorio MD
2 years
Advances in RT for HNC ! @Atem84 @Valerio_Nardone @umbertoricardi 3 weeks left to submit! @FrontOncology
@FrontOncology
Frontiers - Oncology
2 years
📢3 weeks left to submit!📢 The research topic 'Advances in Radiotherapy for Head and Neck Cancer' is closing for submissions soon Led by @peppinoiorio, Nerina Denaro, Isacco Desideri, Umberto Ricardi, Valerio Nardone and Lorenzo Livi Submit here 👉 https://t.co/F3FkDfJuGY
0
4
3
@FIL_ETS
FIL_ETS
3 years
Dopo due anni di stop si è svolta il 14 e 15 aprile la sesta edizione di 'The Young Side of Lymphoma' a Milano, un incontro di due giorni tra giovani medici e biologi attivi nella ricerca sui linfomi. Grazie a tutti i partecipanti! #lymphoma #meeting #ricerca
0
2
9